22157.jpg
COVID-19 Tests Market Landscape 2024: Size, Segments, Share, Regulatory, Reimbursement, and Forecasts 2020-2033
19 août 2024 07h37 HE | Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global COVID-19 Testing Strategic Business Report 2023-2030 - The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms
26 sept. 2023 05h53 HE | Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Testing Market to...
22157.jpg
Global COVID-19 Sample Collection Kits Research Report 2023-2030: Emerging Players Drive Revenue Growth Amid Shortage of Testing Materials
04 août 2023 04h03 HE | Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Sample Collection Kits Market Size, Share & Trends Analysis Report By Product (Swabs, Viral Transport Media), By Application, By Site of...
Global Market for COVID-19 Testing
Global COVID-19 Testing Strategic Business Report 2023: Market to Lose $18.4 Billion in Value to 2030
05 mai 2023 09h03 HE | Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Testing Market to Reach...
The blue and green boxed packaging of the FDA EUA authorized Lucira COVID-19 & Flu Home Test pictured next to the test device itself
Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
27 févr. 2023 08h00 HE | Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
22157.jpg
Global Covid-19 Diagnostic Market Report 2023: Testing Moves to the Home in Fundamental Shift for the Industry
30 janv. 2023 05h13 HE | Research and Markets
Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Covid-19 Diagnostic Market Forecast by Technology, Product, Channel and Country with Executive and Consultant Guides" report has been added to ...
Featured Image for P23 Health
P23 Health E-Commerce Well-Being Company Just Launched in Partnership With P23 Labs, a Renowned Molecular Laboratory
03 nov. 2022 09h15 HE | P23 Health
SAVANNAH, Ga., Nov. 03, 2022 (GLOBE NEWSWIRE) -- P23 Health is a newly formed digital healthcare and wellness company under the P23 umbrella. P23 Health's strategic partner is acknowledged molecular...
Lucira COVID-19 & Flu Test – the 99% Accurate At-Home Test for Covid and Flu
Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test
11 août 2022 07h01 HE | Lucira Health Inc.
EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and...
22157.jpg
Global COVID-19 Diagnostics Markets Report 2022: A Dynamic Market as Multiple Competitors are Vying for the Very Lucrative Future for Respiratory Diagnostics
29 mars 2022 05h03 HE | Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics: Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country - Assay Volumes and Market Size Outlook....
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
07 mars 2022 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye...